The liquid Kangfuxin (KFX) has efficient antifungal activity and can be used in the treatment of vulvovaginal candidiasis in mice
Vulvovaginal candidiasis (VVC) is an infectious disease caused mainly by Candida albicans. Kangfuxin (KFX) is a traditional Chinese medicine preparation made from Periplaneta americana extracts, which promotes wound healing and enhances body immunity and also acts as an antifungal agent. Here, we ev...
Saved in:
Published in | Letters in applied microbiology Vol. 74; no. 4; pp. 564 - 576 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
01.04.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Vulvovaginal candidiasis (VVC) is an infectious disease caused mainly by Candida albicans. Kangfuxin (KFX) is a traditional Chinese medicine preparation made from Periplaneta americana extracts, which promotes wound healing and enhances body immunity and also acts as an antifungal agent. Here, we evaluated the effect of KFX in the treatment of VVC in vitro and in vivo. The minimum inhibitory concentration (MIC50) of KFX against C. albicans ranged from 7·65 to 20·57%. In addition, KFX was more efficient than fluconazole (FLC) in inhibiting the drug‐resistant C. albicans, and the effect was more intense after 8 h. The KFX treatment also exhibited good activity in vivo. It restored the body weight and reduced the vulvovaginal symptoms in mice induced with VVC. It downregulated the expression of the hyphae‐related gene, HWP1, thus inhibiting the growth and development of C. albicans hyphae. It also increased the number of neutrophils and promoted the secretion of interleukin‐17A (IL‐17A); however, the levels of interleukin‐8 (IL‐8) and interleukin‐1β (IL‐1β) decreased in mice with VVC. We deduce that KFX effectively treats vaginal candidiasis in two ways: by inhibiting the growth and development of mycelia to reduce colonization of C. albicans and by promoting the secretion and release of IL‐17A and neutrophils in high numbers to fight C. albicans infection. This study provides a theoretical basis for the use of KFX for the clinical treatment of VVC.
Significance and Impact of the Study: Vulvovaginal candidiasis (VVC) is an infectious disease of the female external reproductive tract, caused by the ecological imbalance in the vagina due to the influence of various pathogenic factors, which brings harm to women's physical and mental health. However, the availability of drugs is limited and the frequency of drug‐resistant Candida isolates is increasing. It is urgent to find new drugs or effective treatment strategies. We found that Kangfuxin liquid (KFX) can be used to treat VVC by reducing mycelial growth and boosting immunity, which presents a new clinical alternative. |
---|---|
AbstractList | Abstract
Vulvovaginal candidiasis (VVC) is an infectious disease caused mainly by Candida albicans. Kangfuxin (KFX) is a traditional Chinese medicine preparation made from Periplaneta americana extracts, which promotes wound healing and enhances body immunity and also acts as an antifungal agent. Here, we evaluated the effect of KFX in the treatment of VVC in vitro and in vivo. The minimum inhibitory concentration (MIC50) of KFX against C. albicans ranged from 7·65 to 20·57%. In addition, KFX was more efficient than fluconazole (FLC) in inhibiting the drug-resistant C. albicans, and the effect was more intense after 8 h. The KFX treatment also exhibited good activity in vivo. It restored the body weight and reduced the vulvovaginal symptoms in mice induced with VVC. It downregulated the expression of the hyphae-related gene, HWP1, thus inhibiting the growth and development of C. albicans hyphae. It also increased the number of neutrophils and promoted the secretion of interleukin-17A (IL-17A); however, the levels of interleukin-8 (IL-8) and interleukin-1β (IL-1β) decreased in mice with VVC. We deduce that KFX effectively treats vaginal candidiasis in two ways: by inhibiting the growth and development of mycelia to reduce colonization of C. albicans and by promoting the secretion and release of IL-17A and neutrophils in high numbers to fight C. albicans infection. This study provides a theoretical basis for the use of KFX for the clinical treatment of VVC. Vulvovaginal candidiasis (VVC) is an infectious disease caused mainly by Candida albicans. Kangfuxin (KFX) is a traditional Chinese medicine preparation made from Periplaneta americana extracts, which promotes wound healing and enhances body immunity and also acts as an antifungal agent. Here, we evaluated the effect of KFX in the treatment of VVC in vitro and in vivo. The minimum inhibitory concentration (MIC50) of KFX against C. albicans ranged from 7·65 to 20·57%. In addition, KFX was more efficient than fluconazole (FLC) in inhibiting the drug‐resistant C. albicans, and the effect was more intense after 8 h. The KFX treatment also exhibited good activity in vivo. It restored the body weight and reduced the vulvovaginal symptoms in mice induced with VVC. It downregulated the expression of the hyphae‐related gene, HWP1, thus inhibiting the growth and development of C. albicans hyphae. It also increased the number of neutrophils and promoted the secretion of interleukin‐17A (IL‐17A); however, the levels of interleukin‐8 (IL‐8) and interleukin‐1β (IL‐1β) decreased in mice with VVC. We deduce that KFX effectively treats vaginal candidiasis in two ways: by inhibiting the growth and development of mycelia to reduce colonization of C. albicans and by promoting the secretion and release of IL‐17A and neutrophils in high numbers to fight C. albicans infection. This study provides a theoretical basis for the use of KFX for the clinical treatment of VVC. Vulvovaginal candidiasis (VVC) is an infectious disease caused mainly by Candida albicans. Kangfuxin (KFX) is a traditional Chinese medicine preparation made from Periplaneta americana extracts, which promotes wound healing and enhances body immunity and also acts as an antifungal agent. Here, we evaluated the effect of KFX in the treatment of VVC in vitro and in vivo. The minimum inhibitory concentration (MIC50) of KFX against C. albicans ranged from 7·65 to 20·57%. In addition, KFX was more efficient than fluconazole (FLC) in inhibiting the drug‐resistant C. albicans, and the effect was more intense after 8 h. The KFX treatment also exhibited good activity in vivo. It restored the body weight and reduced the vulvovaginal symptoms in mice induced with VVC. It downregulated the expression of the hyphae‐related gene, HWP1, thus inhibiting the growth and development of C. albicans hyphae. It also increased the number of neutrophils and promoted the secretion of interleukin‐17A (IL‐17A); however, the levels of interleukin‐8 (IL‐8) and interleukin‐1β (IL‐1β) decreased in mice with VVC. We deduce that KFX effectively treats vaginal candidiasis in two ways: by inhibiting the growth and development of mycelia to reduce colonization of C. albicans and by promoting the secretion and release of IL‐17A and neutrophils in high numbers to fight C. albicans infection. This study provides a theoretical basis for the use of KFX for the clinical treatment of VVC. Significance and Impact of the Study: Vulvovaginal candidiasis (VVC) is an infectious disease of the female external reproductive tract, caused by the ecological imbalance in the vagina due to the influence of various pathogenic factors, which brings harm to women's physical and mental health. However, the availability of drugs is limited and the frequency of drug‐resistant Candida isolates is increasing. It is urgent to find new drugs or effective treatment strategies. We found that Kangfuxin liquid (KFX) can be used to treat VVC by reducing mycelial growth and boosting immunity, which presents a new clinical alternative. Vulvovaginal candidiasis (VVC) is an infectious disease caused mainly by Candida albicans. Kangfuxin (KFX) is a traditional Chinese medicine preparation made from Periplaneta americana extracts, which promotes wound healing and enhances body immunity and also acts as an antifungal agent. Here, we evaluated the effect of KFX in the treatment of VVC in vitro and in vivo. The minimum inhibitory concentration (MIC ) of KFX against C. albicans ranged from 7·65 to 20·57%. In addition, KFX was more efficient than fluconazole (FLC) in inhibiting the drug-resistant C. albicans, and the effect was more intense after 8 h. The KFX treatment also exhibited good activity in vivo. It restored the body weight and reduced the vulvovaginal symptoms in mice induced with VVC. It downregulated the expression of the hyphae-related gene, HWP1, thus inhibiting the growth and development of C. albicans hyphae. It also increased the number of neutrophils and promoted the secretion of interleukin-17A (IL-17A); however, the levels of interleukin-8 (IL-8) and interleukin-1β (IL-1β) decreased in mice with VVC. We deduce that KFX effectively treats vaginal candidiasis in two ways: by inhibiting the growth and development of mycelia to reduce colonization of C. albicans and by promoting the secretion and release of IL-17A and neutrophils in high numbers to fight C. albicans infection. This study provides a theoretical basis for the use of KFX for the clinical treatment of VVC. |
Author | Wang, R.‐R. Qin, D.‐M. Yang, Y.‐C. Su, L.‐Q. Yuan, K. Ma, J. Zhang, Y. |
Author_xml | – sequence: 1 givenname: J. orcidid: 0000-0003-3014-012X surname: Ma fullname: Ma, J. organization: Dali University – sequence: 2 givenname: Y.‐C. surname: Yang fullname: Yang, Y.‐C. organization: Yunnan University of Chinese Medicine – sequence: 3 givenname: L.‐Q. surname: Su fullname: Su, L.‐Q. organization: Yunnan University of Chinese Medicine – sequence: 4 givenname: D.‐M. surname: Qin fullname: Qin, D.‐M. organization: Yunnan University of Chinese Medicine – sequence: 5 givenname: K. surname: Yuan fullname: Yuan, K. organization: Yunnan University of Chinese Medicine – sequence: 6 givenname: Y. surname: Zhang fullname: Zhang, Y. organization: Yunnan University of Chinese Medicine – sequence: 7 givenname: R.‐R. surname: Wang fullname: Wang, R.‐R. email: wangrryucm@126.com organization: Yunnan University of Chinese Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34958703$$D View this record in MEDLINE/PubMed |
BookMark | eNp10btKBDEUBuAgiq6XwheQgI0Wo7lMkk0pizdcsVGwGzK5rJGZjE4mq1v65mZdtRBMc-DwnZ_Avw3WQxcsAPsYneD8ThvVnmDKS7wGRrgUpBCcPa6DESKcF2PCyi2wHeMzQmiMidwEW7SUbCwQHYGP-ycLG_-avIE3KsxcevcBHt1cPB7DJxWhdc5rb8MAVRi8S2GmGqj04Od-WOSdgVoFWFuYojUwnw45b-itGtrlUefgPDXzbq5mPuTLjI03XkUfl7j12u6CDaeaaPe-5w54uDi_n1wV07vL68nZtNCUUVxorVwpECNCCYxlzbVBkmvkjDC1plqyUiFiJBd5UztGxhRz7Jysa8GkZHQHHK1yX_ruNdk4VK2P2jaNCrZLsSIcM0yIKGmmh3_oc5f6_P-lohJRISnP6nildN_F2FtXvfS-Vf2iwqha9lLlXqqvXrI9-E5MdWvNr_wpIoPTFXjzjV38n1RNz25XkZ8qe5jr |
CitedBy_id | crossref_primary_10_1155_2022_1664225 crossref_primary_10_1016_j_heliyon_2024_e31182 |
Cites_doi | 10.1093/emboj/16.8.1982 10.1007/s00253-019-10119-3 10.1038/nature10957 10.2147/IDR.S305503 10.1016/j.bbrc.2004.05.029 10.1128/IAI.06146-11 10.1091/mbc.12.11.3631 10.1095/biolreprod.113.109397 10.1016/j.ijmm.2005.12.017 10.1038/nri1785 10.1080/10611860500422958 10.1155/2020/8841113 10.1586/14787210.2014.916210 10.1177/1933719114534536 10.4103/0973-1296.185771 10.1016/S0254-6272(13)60103-X 10.1186/1471-2334-6-55 10.1111/j.1348-0421.2007.tb04008.x 10.1099/jmm.0.46737-0 10.1093/jme/tjz081 10.1080/14656566.2018.1476490 10.1371/journal.pone.0022770 10.3389/fmicb.2020.01648 10.2147/IDR.S226154 10.1128/EC.00279-10 10.1128/AAC.01065-17 10.1371/journal.pone.0243197 10.1093/infdis/jiz579 10.1097/AOG.0b013e31827307b2 10.1016/S0140-6736(07)60917-9 10.1111/myc.12920 10.2174/1389201022666210218193445 10.1016/j.bioorg.2020.104256 10.1007/s11046-015-9947-5 10.1155/2019/1324969 10.1186/s13104-019-4793-z 10.1097/MD.0000000000016895 10.14260/jemds/80 10.1038/cmi.2012.1 10.2147/IJN.S92638 10.1093/clinids/22.4.726 10.1111/lam.13458 10.1046/j.1365-2958.2001.02672.x 10.3389/fimmu.2019.02364 10.1038/nature17625 |
ContentType | Journal Article |
Copyright | 2021 The Society for Applied Microbiology 2021 The Society for Applied Microbiology. Copyright © 2022 The Society for Applied Microbiology |
Copyright_xml | – notice: 2021 The Society for Applied Microbiology – notice: 2021 The Society for Applied Microbiology. – notice: Copyright © 2022 The Society for Applied Microbiology |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL 7QO 7ST 7T7 7TM 8FD C1K FR3 M7N P64 SOI 7X8 |
DOI | 10.1111/lam.13641 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Environment Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Environment Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Biotechnology Research Abstracts Technology Research Database Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Nucleic Acids Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Environment Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | CrossRef Biotechnology Research Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1472-765X |
EndPage | 576 |
ExternalDocumentID | 10_1111_lam_13641 34958703 LAM13641 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: the Foundation of Scientific Research Project of the National Natural Science Foundation of China funderid: 81660737 – fundername: Scientific Research Foundation of Education Department of Yunnan Province funderid: 2014Y238 – fundername: The Joint Special Fund of Yunnan Provincial Science and Technology Department funderid: 2017FF117‐025 – fundername: Yunnan Provincial Department of Science and Technology and Yunnan University of Traditional Chinese Medicine applied basic Research Joint Special Project funderid: 2017FF116‐028 – fundername: The Joint Special Fund of Science and Technology Department of Yunnan Province‐Yunnan University of Chinese Medicine funderid: 2017FF117‐003 – fundername: The Joint Special Fund of Yunnan Provincial Science and Technology Department grantid: 2017FF117-025 – fundername: the Foundation of Scientific Research Project of the National Natural Science Foundation of China grantid: 81660737 – fundername: The Joint Special Fund of Science and Technology Department of Yunnan Province-Yunnan University of Chinese Medicine grantid: 2017FF117-003 – fundername: Yunnan Provincial Department of Science and Technology and Yunnan University of Traditional Chinese Medicine applied basic Research Joint Special Project grantid: 2017FF116-028 – fundername: Scientific Research Foundation of Education Department of Yunnan Province grantid: 2014Y238 |
GroupedDBID | --- -~X .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 24P 29L 2WC 31~ 33P 36B 3EH 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 5WD 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHBH AAHHS AAONW AAPXW AARHZ AASGY AAUAY AAVAP AAWDT AAXRX AAZKR ABCQN ABCUV ABEML ABJNI ABMNT ABPTD ABPVW ABWST ABXVV ABXZS ACAHQ ACBWZ ACCFJ ACCZN ACFRR ACGFO ACGFS ACIWK ACPOU ACPRK ACSCC ACUTJ ACXBN ACXQS ACZBC ADBBV ADEOM ADIPN ADIZJ ADKYN ADMGS ADOZA ADQBN ADVEK ADXAS ADZMN AEEZP AEGXH AEIMD AENEX AEQDE AEUQT AFBPY AFEBI AFFNX AFGKR AFGWE AFPWT AFRAH AFYAG AFZJQ AGMDO AGQXC AHEFC AIAGR AIURR AIWBW AJAOE AJBDE AJEEA AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ANFBD APJGH ASPBG ATGXG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BCRHZ BDRZF BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 C45 CAG COF CS3 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRSTM DU5 E3Z EBS EJD EMOBN ESX F00 F01 F04 F5P FEDTE FIJ FSRTE FZ0 G-S G.N GODZA H.T H.X H13 HF~ HVGLF HZI HZ~ H~9 IHE IPNFZ IX1 J0M K48 KOP LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MK4 MRFUL MRSTM MSFUL MSSTM MVM MXFUL MXSTM N04 N05 N9A NF~ O66 O9- OBOKY OIG OJZSN OK1 OVD OWPYF P2P P2W P2X P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL ROX RX1 SUPJJ TCN TEORI UB1 V8K W8V W99 WBKPD WH7 WIH WIK WIN WNSPC WOHZO WQJ WRC WYISQ XG1 Y6R YOC ZCG ZZTAW ~02 ~IA ~KM ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL 7QO 7ST 7T7 7TM 8FD C1K FR3 M7N P64 SOI 7X8 |
ID | FETCH-LOGICAL-c3531-ccaf470527a7119b6cd096c0fd7dbc3c954a02d967fd7bf5283161ff9bb759953 |
IEDL.DBID | DR2 |
ISSN | 0266-8254 |
IngestDate | Fri Aug 16 07:32:09 EDT 2024 Thu Oct 10 19:15:56 EDT 2024 Fri Aug 23 00:52:40 EDT 2024 Tue Aug 27 13:50:30 EDT 2024 Sat Aug 24 00:57:11 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Candida albicans antifungal vaginal candidiasis murine model Kangfuxin liquid |
Language | English |
License | 2021 The Society for Applied Microbiology. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3531-ccaf470527a7119b6cd096c0fd7dbc3c954a02d967fd7bf5283161ff9bb759953 |
Notes | J. Ma and Y.‐C. Yang contributed equally to this work. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-3014-012X |
PMID | 34958703 |
PQID | 2639037936 |
PQPubID | 1006551 |
PageCount | 576 |
ParticipantIDs | proquest_miscellaneous_2615122743 proquest_journals_2639037936 crossref_primary_10_1111_lam_13641 pubmed_primary_34958703 wiley_primary_10_1111_lam_13641_LAM13641 |
PublicationCentury | 2000 |
PublicationDate | April 2022 2022-Apr 2022-04-01 20220401 |
PublicationDateYYYYMMDD | 2022-04-01 |
PublicationDate_xml | – month: 04 year: 2022 text: April 2022 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | Letters in applied microbiology |
PublicationTitleAlternate | Lett Appl Microbiol |
PublicationYear | 2022 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | 2017; 61 2012; 80 2012; 120 2019; 2019 2012; 484 2014; 90 2007; 369 2021; 22 2019; 10 2019; 98 2006; 55 2019; 12 2019; 56 2015; 10 2020; 104 2020; 15 2019; 103 2006; 296 2011; 10 2006; 6 2020; 13 2020; 221 2007; 51 2020; 11 2021; 72 2016; 181 2011; 6 2016; 12 2001; 42 2021; 14 2018; 19 2020; 2020 2019; 62 2012; 1 2013; 33 2015; 22 1997; 16 2016; 532 2001; 12 2014; 12 2005; 13 2012; 9 2004; 319 1996; 22 Apalata (2023011712223657900_lam13641-bib-0003) 2020; 2020 Dos Santos Ramos (2023011712223657900_lam13641-bib-0013) 2015; 10 Hosseini (2023011712223657900_lam13641-bib-0019) 2020; 13 Sherry (2023011712223657900_lam13641-bib-0034) 2017; 61 Chen (2023011712223657900_lam13641-bib-0009) 2019; 103 Sobel (2023011712223657900_lam13641-bib-0036) 2018; 19 Ghosh (2023011712223657900_lam13641-bib-0016) 2020; 221 Marchaim (2023011712223657900_lam13641-bib-0025) 2012; 120 Borghi (2023011712223657900_lam13641-bib-0006) 2019; 10 Moyes (2023011712223657900_lam13641-bib-0027) 2016; 532 Naglik (2023011712223657900_lam13641-bib-0029) 2006; 55 Chatzivasileiou (2023011712223657900_lam13641-bib-0008) 2019; 62 Ahmad (2023011712223657900_lam13641-bib-0001) 2005; 13 Leberer (2023011712223657900_lam13641-bib-0022) 2001; 42 Shen (2023011712223657900_lam13641-bib-0033) 2020; 11 Pietrella (2023011712223657900_lam13641-bib-0031) 2011; 6 Zou (2023011712223657900_lam13641-bib-0044) 2019; 2019 Bonfim (2023011712223657900_lam13641-bib-0005) 2020; 15 Dias (2023011712223657900_lam13641-bib-0012) 2014; 90 Liu (2023011712223657900_lam13641-bib-0024) 2011; 10 Wang (2023011712223657900_lam13641-bib-0040) 2016; 181 Zuluaga (2023011712223657900_lam13641-bib-0045) 2006; 6 Lin (2023011712223657900_lam13641-bib-0023) 2004; 319 Ganeshkumar (2023011712223657900_lam13641-bib-0015) 2020; 104 Mushi (2023011712223657900_lam13641-bib-0028) 2019; 12 Nathan (2023011712223657900_lam13641-bib-0030) 2006; 6 Sobel (2023011712223657900_lam13641-bib-0035) 2007; 369 Cheng (2023011712223657900_lam13641-bib-0010) 2012; 80 Hebecker (2023011712223657900_lam13641-bib-0017) 2014; 12 Wang (2023011712223657900_lam13641-bib-0039) 2021; 72 Egusa (2023011712223657900_lam13641-bib-0014) 2006; 296 Stoldt (2023011712223657900_lam13641-bib-0038) 1997; 16 Zielinski (2023011712223657900_lam13641-bib-0043) 2012; 484 Bhat (2023011712223657900_lam13641-bib-0004) 2012; 1 Jia (2023011712223657900_lam13641-bib-0020) 2019; 98 Allemailem (2023011712223657900_lam13641-bib-0002) 2021; 22 Rocha (2023011712223657900_lam13641-bib-0032) 2001; 12 Sobel (2023011712223657900_lam13641-bib-0037) 1996; 22 Zeng (2023011712223657900_lam13641-bib-0041) 2019; 56 Zhang (2023011712223657900_lam13641-bib-0042) 2013; 33 Hertiani (2023011712223657900_lam13641-bib-0018) 2016; 12 Khan (2023011712223657900_lam13641-bib-0021) 2021; 14 Carvalho (2023011712223657900_lam13641-bib-0007) 2012; 9 Matsuzaki (2023011712223657900_lam13641-bib-0026) 2007; 51 Di Spiezio Sardo (2023011712223657900_lam13641-bib-0011) 2015; 22 |
References_xml | – volume: 22 start-page: 1812 year: 2021 end-page: 1820 article-title: Prophylactic and therapeutic role of vitamin D3 in combination with fluconazole against vaginal candidiasis in a murine model publication-title: Curr Pharm Biotechno – volume: 103 start-page: 9037 year: 2019 end-page: 9055 article-title: Cinnamaldehyde inhibits growth by causing apoptosis and its treatment on vulvovaginal candidiasis and oropharyngeal candidiasis publication-title: Appl Microbiol Biotechnol – volume: 221 start-page: 1185 year: 2020 end-page: 1193 article-title: Targeting parasite‐produced macrophage migration inhibitory factor as an antivirulence strategy with antibiotic‐antibody combination to reduce tissue damage publication-title: J Infect Dis – volume: 6 start-page: 55 year: 2006 article-title: Neutropenia induced in outbred mice by a simplified low‐dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases publication-title: BMC Infect Dis – volume: 2020 start-page: 1 year: 2020 end-page: 10 article-title: The role of T helper 17 (Th17) and regulatory T cells (Treg) in the pathogenesis of vulvovaginal candidiasis among HIV‐infected women publication-title: Int J Microbiol – volume: 296 start-page: 301 year: 2006 end-page: 311 article-title: In vitro mechanisms of interleukin‐8‐mediated responses of human gingival epithelial cells to infection publication-title: Int J Med Microbiol – volume: 9 start-page: 276 year: 2012 end-page: 286 article-title: Dectin‐1 isoforms contribute to distinct Th1/Th17 cell activation in mucosal candidiasis publication-title: Cell Mol Immunol – volume: 11 start-page: 1648 year: 2020 article-title: Dectin‐1 facilitates IL‐18 production for the generation of protective antibodies against publication-title: Front Microbiol – volume: 13 start-page: 385 year: 2020 end-page: 394 article-title: Antifungal activity of ZnO nanoparticles and nystatin and downregulation of SAP1‐3 genes expression in fluconazole‐resistant isolates from vulvovaginal candidiasis publication-title: Infect Drug Resist – volume: 532 start-page: 64 year: 2016 end-page: 68 article-title: Candidalysin is a fungal peptide toxin critical for mucosal infection publication-title: Nature – volume: 369 start-page: 1961 year: 2007 end-page: 1971 article-title: Vulvovaginal candidosis publication-title: Lancet – volume: 22 start-page: 124 year: 2015 end-page: 131 article-title: The potential role of endometrial nerve fibers in the pathogenesis of pain during endometrial biopsy at office hysteroscopy publication-title: Reprod Sci – volume: 72 start-page: 688 year: 2021 end-page: 697 article-title: The synergistic antifungal activity of resveratrol with azoles against publication-title: Lett Appl Microbiol – volume: 12 start-page: 867 year: 2014 end-page: 879 article-title: Pathogenicity mechanisms and host response during oral infections publication-title: Expert Rev Anti Infect Ther – volume: 98 year: 2019 article-title: Low‐dose methotrexate‐induced vulvar edema: a case report publication-title: Medicine – volume: 12 start-page: 775 year: 2019 article-title: vaginitis among symptomatic pregnant women attending antenatal clinics in Mwanza, Tanzania publication-title: BMC Res Notes – volume: 55 start-page: 1323 year: 2006 end-page: 1327 article-title: HWP1 gene expression and host antibody responses in colonization and disease publication-title: J Med Microbiol – volume: 1 start-page: 509 year: 2012 end-page: 513 article-title: Microbiological profile of vaginal swabs publication-title: J Evol Med Dental Sci – volume: 62 start-page: 638 year: 2019 end-page: 650 article-title: Vaginal yeast colonisation: from a potential harmless condition to clinical implications and management approaches – a literature review publication-title: Mycoses – volume: 6 start-page: 173 year: 2006 end-page: 182 article-title: Neutrophils and immunity: challenges and opportunities publication-title: Nat Rev Immunol – volume: 6 year: 2011 article-title: Th17 cells and IL‐17 in protective immunity to vaginal candidiasis publication-title: PLoS One – volume: 10 start-page: 7455 year: 2015 end-page: 7466 article-title: Liquid crystal precursor mucoadhesive system as a strategy to improve the prophylactic action of (Bong.) Ruhland against infection by publication-title: Int J Nanomed – volume: 12 start-page: S363 year: 2016 end-page: S370 article-title: Potency of Massoia bark in combating immunosuppressed‐related infection publication-title: Pharmacogn Mag – volume: 51 start-page: 1139 year: 2007 end-page: 1147 article-title: Interleukin‐17 as an effector molecule of innate and acquired immunity against infections publication-title: Microbiol Immunol – volume: 181 start-page: 29 year: 2016 end-page: 39 article-title: Combination of estrogen and immunosuppressive agents to establish a mouse model of candidiasis with concurrent oral and vaginal mucosal infection publication-title: Mycopathologia – volume: 13 start-page: 555 year: 2005 end-page: 561 article-title: Antimicrobial activity of clove oil and its potential in the treatment of vaginal candidiasis publication-title: J Drug Target – volume: 42 start-page: 673 year: 2001 end-page: 687 article-title: Ras links cellular morphogenesis to virulence byregulation of the MAP kinase and cAMP signalling pathways in the pathogenic fungus publication-title: Mol Microbiolol – volume: 319 start-page: 576 year: 2004 end-page: 581 article-title: Effective neutrophil chemotaxis is strongly influenced by mean IL‐8 concentration publication-title: Biochem Biophys Res Commun – volume: 10 start-page: 2364 year: 2019 article-title: Targeting the aryl hydrocarbon receptor with indole‐3‐aldehyde protects from vulvovaginal candidiasis via the IL‐22‐IL‐18 cross‐talk publication-title: Front Immunol – volume: 33 start-page: 70 year: 2013 end-page: 73 article-title: Protective effect of extract on intestinal mucosal barrier function in patients with sepsis publication-title: J Trad Chin Med – volume: 80 start-page: 1304 year: 2012 end-page: 1313 article-title: Interplay between and the mammalian innate host defense publication-title: Infect Immun – volume: 90 start-page: 19 year: 2014 article-title: Inhibition of follicle‐stimulating hormone‐induced preovulatory follicles in rats treated with a nonsteroidal negative allosteric modulator of follicle‐stimulating hormone receptor publication-title: Biol Reprod – volume: 15 year: 2020 article-title: Preclinical approaches in vulvovaginal candidiasis treatment with mucoadhesive thermoresponsive systems containing propolis publication-title: PLoS One – volume: 19 start-page: 971 year: 2018 end-page: 977 article-title: Current treatment options for vulvovaginal candidiasis caused by azole‐resistant species publication-title: Expert Opin Pharmacother – volume: 120 start-page: 1407 year: 2012 end-page: 1414 article-title: Fluconazole‐resistant vulvovaginitis publication-title: Obstet Gynecol – volume: 12 start-page: 3631 year: 2001 end-page: 3643 article-title: Signaling through adenylyl cyclase is essential for hyphal growth and virulence in the pathogenic fungus publication-title: Mol Biol Cell – volume: 14 start-page: 1585 year: 2021 end-page: 1599 article-title: Coadministration of ginger extract and fluconazole shows a synergistic effect in the treatment of drug‐resistant vulvovaginal candidiasis publication-title: Infect Drug Resist – volume: 61 start-page: e01065 year: 2017 end-page: 17 article-title: Biofilms formed by isolates from recurrent vulvovaginal candidiasis patients are heterogeneous and insensitive to fluconazole publication-title: Antimicrob Agents Chemother – volume: 484 start-page: 514 year: 2012 end-page: 518 article-title: Pathogen‐induced human TH17 cells produce IFN‐gamma or IL‐10 and are regulated by IL‐1β publication-title: Nature – volume: 10 start-page: 168 year: 2011 end-page: 173 article-title: Als3, a multifunctional adhesin and invasin publication-title: Eukaryot Cell – volume: 16 start-page: 1982 year: 1997 end-page: 1991 article-title: Efg1p, an essential regulator of morphogenesis of the human pathogen , is a member of a conserved class of bhlh proteins regulating morphogenetic processes in fungi publication-title: EMBO J – volume: 56 start-page: 1522 year: 2019 end-page: 1526 article-title: The role of (Blattodea: Blattidae) in modern versus traditional Chinese medicine publication-title: J Med Entomol – volume: 2019 start-page: 1324969 year: 2019 article-title: Therapeutic efficacy of Kangfuxin liquid combined with PPIs in gastric ulcer publication-title: Evid Based Complement Alternat Med – volume: 104 year: 2020 article-title: New insight of red seaweed derived Callophycin A as an alternative strategy to treat drug resistance vaginal candidiasis publication-title: Bioorg Chem – volume: 22 start-page: 726 year: 1996 end-page: 727 article-title: Symptomatic vulvovaginitis due to fluconazole‐resistant in a female who was not infected with human immunodeficiency virus publication-title: Clin Infect Dis – volume: 16 start-page: 1982 year: 1997 ident: 2023011712223657900_lam13641-bib-0038 article-title: Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bhlh proteins regulating morphogenetic processes in fungi publication-title: EMBO J doi: 10.1093/emboj/16.8.1982 contributor: fullname: Stoldt – volume: 103 start-page: 9037 year: 2019 ident: 2023011712223657900_lam13641-bib-0009 article-title: Cinnamaldehyde inhibits Candida albicans growth by causing apoptosis and its treatment on vulvovaginal candidiasis and oropharyngeal candidiasis publication-title: Appl Microbiol Biotechnol doi: 10.1007/s00253-019-10119-3 contributor: fullname: Chen – volume: 484 start-page: 514 year: 2012 ident: 2023011712223657900_lam13641-bib-0043 article-title: Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1β publication-title: Nature doi: 10.1038/nature10957 contributor: fullname: Zielinski – volume: 14 start-page: 1585 year: 2021 ident: 2023011712223657900_lam13641-bib-0021 article-title: Coadministration of ginger extract and fluconazole shows a synergistic effect in the treatment of drug-resistant vulvovaginal candidiasis publication-title: Infect Drug Resist doi: 10.2147/IDR.S305503 contributor: fullname: Khan – volume: 319 start-page: 576 year: 2004 ident: 2023011712223657900_lam13641-bib-0023 article-title: Effective neutrophil chemotaxis is strongly influenced by mean IL-8 concentration publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2004.05.029 contributor: fullname: Lin – volume: 80 start-page: 1304 year: 2012 ident: 2023011712223657900_lam13641-bib-0010 article-title: Interplay between Candida albicans and the mammalian innate host defense publication-title: Infect Immun doi: 10.1128/IAI.06146-11 contributor: fullname: Cheng – volume: 12 start-page: 3631 year: 2001 ident: 2023011712223657900_lam13641-bib-0032 article-title: Signaling through adenylyl cyclase is essential for hyphal growth and virulence in the pathogenic fungus Candida albicans publication-title: Mol Biol Cell doi: 10.1091/mbc.12.11.3631 contributor: fullname: Rocha – volume: 90 start-page: 19 year: 2014 ident: 2023011712223657900_lam13641-bib-0012 article-title: Inhibition of follicle-stimulating hormone-induced preovulatory follicles in rats treated with a nonsteroidal negative allosteric modulator of follicle-stimulating hormone receptor publication-title: Biol Reprod doi: 10.1095/biolreprod.113.109397 contributor: fullname: Dias – volume: 296 start-page: 301 year: 2006 ident: 2023011712223657900_lam13641-bib-0014 article-title: In vitro mechanisms of interleukin-8-mediated responses of human gingival epithelial cells to Candida albicans infection publication-title: Int J Med Microbiol doi: 10.1016/j.ijmm.2005.12.017 contributor: fullname: Egusa – volume: 6 start-page: 173 year: 2006 ident: 2023011712223657900_lam13641-bib-0030 article-title: Neutrophils and immunity: challenges and opportunities publication-title: Nat Rev Immunol doi: 10.1038/nri1785 contributor: fullname: Nathan – volume: 13 start-page: 555 year: 2005 ident: 2023011712223657900_lam13641-bib-0001 article-title: Antimicrobial activity of clove oil and its potential in the treatment of vaginal candidiasis publication-title: J Drug Target doi: 10.1080/10611860500422958 contributor: fullname: Ahmad – volume: 2020 start-page: 1 year: 2020 ident: 2023011712223657900_lam13641-bib-0003 article-title: The role of T helper 17 (Th17) and regulatory T cells (Treg) in the pathogenesis of vulvovaginal candidiasis among HIV-infected women publication-title: Int J Microbiol doi: 10.1155/2020/8841113 contributor: fullname: Apalata – volume: 12 start-page: 867 year: 2014 ident: 2023011712223657900_lam13641-bib-0017 article-title: Pathogenicity mechanisms and host response during oral Candida albicans infections publication-title: Expert Rev Anti Infect Ther doi: 10.1586/14787210.2014.916210 contributor: fullname: Hebecker – volume: 22 start-page: 124 year: 2015 ident: 2023011712223657900_lam13641-bib-0011 article-title: The potential role of endometrial nerve fibers in the pathogenesis of pain during endometrial biopsy at office hysteroscopy publication-title: Reprod Sci doi: 10.1177/1933719114534536 contributor: fullname: Di Spiezio Sardo – volume: 12 start-page: S363 year: 2016 ident: 2023011712223657900_lam13641-bib-0018 article-title: Potency of Massoia bark in combating immunosuppressed-related infection publication-title: Pharmacogn Mag doi: 10.4103/0973-1296.185771 contributor: fullname: Hertiani – volume: 33 start-page: 70 year: 2013 ident: 2023011712223657900_lam13641-bib-0042 article-title: Protective effect of Periplaneta americana extract on intestinal mucosal barrier function in patients with sepsis publication-title: J Trad Chin Med doi: 10.1016/S0254-6272(13)60103-X contributor: fullname: Zhang – volume: 6 start-page: 55 year: 2006 ident: 2023011712223657900_lam13641-bib-0045 article-title: Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases publication-title: BMC Infect Dis doi: 10.1186/1471-2334-6-55 contributor: fullname: Zuluaga – volume: 51 start-page: 1139 year: 2007 ident: 2023011712223657900_lam13641-bib-0026 article-title: Interleukin-17 as an effector molecule of innate and acquired immunity against infections publication-title: Microbiol Immunol doi: 10.1111/j.1348-0421.2007.tb04008.x contributor: fullname: Matsuzaki – volume: 55 start-page: 1323 year: 2006 ident: 2023011712223657900_lam13641-bib-0029 article-title: Candida albicans HWP1 gene expression and host antibody responses in colonization and disease publication-title: J Med Microbiol doi: 10.1099/jmm.0.46737-0 contributor: fullname: Naglik – volume: 56 start-page: 1522 year: 2019 ident: 2023011712223657900_lam13641-bib-0041 article-title: The role of Periplaneta americana (Blattodea: Blattidae) in modern versus traditional Chinese medicine publication-title: J Med Entomol doi: 10.1093/jme/tjz081 contributor: fullname: Zeng – volume: 19 start-page: 971 year: 2018 ident: 2023011712223657900_lam13641-bib-0036 article-title: Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species publication-title: Expert Opin Pharmacother doi: 10.1080/14656566.2018.1476490 contributor: fullname: Sobel – volume: 6 year: 2011 ident: 2023011712223657900_lam13641-bib-0031 article-title: Th17 cells and IL-17 in protective immunity to vaginal candidiasis publication-title: PLoS One doi: 10.1371/journal.pone.0022770 contributor: fullname: Pietrella – volume: 11 start-page: 1648 year: 2020 ident: 2023011712223657900_lam13641-bib-0033 article-title: Dectin-1 facilitates IL-18 production for the generation of protective antibodies against Candida albicans publication-title: Front Microbiol doi: 10.3389/fmicb.2020.01648 contributor: fullname: Shen – volume: 13 start-page: 385 year: 2020 ident: 2023011712223657900_lam13641-bib-0019 article-title: Antifungal activity of ZnO nanoparticles and nystatin and downregulation of SAP1-3 genes expression in fluconazole-resistant Candida albicans isolates from vulvovaginal candidiasis publication-title: Infect Drug Resist doi: 10.2147/IDR.S226154 contributor: fullname: Hosseini – volume: 10 start-page: 168 year: 2011 ident: 2023011712223657900_lam13641-bib-0024 article-title: Candida albicans Als3, a multifunctional adhesin and invasin publication-title: Eukaryot Cell doi: 10.1128/EC.00279-10 contributor: fullname: Liu – volume: 61 start-page: e01065 year: 2017 ident: 2023011712223657900_lam13641-bib-0034 article-title: Biofilms formed by isolates from recurrent vulvovaginal candidiasis patients are heterogeneous and insensitive to fluconazole publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01065-17 contributor: fullname: Sherry – volume: 15 year: 2020 ident: 2023011712223657900_lam13641-bib-0005 article-title: Preclinical approaches in vulvovaginal candidiasis treatment with mucoadhesive thermoresponsive systems containing propolis publication-title: PLoS One doi: 10.1371/journal.pone.0243197 contributor: fullname: Bonfim – volume: 221 start-page: 1185 year: 2020 ident: 2023011712223657900_lam13641-bib-0016 article-title: Targeting parasite-produced macrophage migration inhibitory factor as an antivirulence strategy with antibiotic-antibody combination to reduce tissue damage publication-title: J Infect Dis doi: 10.1093/infdis/jiz579 contributor: fullname: Ghosh – volume: 120 start-page: 1407 year: 2012 ident: 2023011712223657900_lam13641-bib-0025 article-title: Fluconazole-resistant Candida albicans vulvovaginitis publication-title: Obstet Gynecol doi: 10.1097/AOG.0b013e31827307b2 contributor: fullname: Marchaim – volume: 369 start-page: 1961 year: 2007 ident: 2023011712223657900_lam13641-bib-0035 article-title: Vulvovaginal candidosis publication-title: Lancet doi: 10.1016/S0140-6736(07)60917-9 contributor: fullname: Sobel – volume: 62 start-page: 638 year: 2019 ident: 2023011712223657900_lam13641-bib-0008 article-title: Vaginal yeast colonisation: from a potential harmless condition to clinical implications and management approaches – a literature review publication-title: Mycoses doi: 10.1111/myc.12920 contributor: fullname: Chatzivasileiou – volume: 22 start-page: 1812 year: 2021 ident: 2023011712223657900_lam13641-bib-0002 article-title: Prophylactic and therapeutic role of vitamin D3 in combination with fluconazole against vaginal candidiasis in a murine model publication-title: Curr Pharm Biotechno doi: 10.2174/1389201022666210218193445 contributor: fullname: Allemailem – volume: 104 year: 2020 ident: 2023011712223657900_lam13641-bib-0015 article-title: New insight of red seaweed derived Callophycin A as an alternative strategy to treat drug resistance vaginal candidiasis publication-title: Bioorg Chem doi: 10.1016/j.bioorg.2020.104256 contributor: fullname: Ganeshkumar – volume: 181 start-page: 29 year: 2016 ident: 2023011712223657900_lam13641-bib-0040 article-title: Combination of estrogen and immunosuppressive agents to establish a mouse model of candidiasis with concurrent oral and vaginal mucosal infection publication-title: Mycopathologia doi: 10.1007/s11046-015-9947-5 contributor: fullname: Wang – volume: 2019 start-page: 1324969 year: 2019 ident: 2023011712223657900_lam13641-bib-0044 article-title: Therapeutic efficacy of Kangfuxin liquid combined with PPIs in gastric ulcer publication-title: Evid Based Complement Alternat Med doi: 10.1155/2019/1324969 contributor: fullname: Zou – volume: 12 start-page: 775 year: 2019 ident: 2023011712223657900_lam13641-bib-0028 article-title: Candida vaginitis among symptomatic pregnant women attending antenatal clinics in Mwanza, Tanzania publication-title: BMC Res Notes doi: 10.1186/s13104-019-4793-z contributor: fullname: Mushi – volume: 98 year: 2019 ident: 2023011712223657900_lam13641-bib-0020 article-title: Low-dose methotrexate-induced vulvar edema: a case report publication-title: Medicine doi: 10.1097/MD.0000000000016895 contributor: fullname: Jia – volume: 1 start-page: 509 year: 2012 ident: 2023011712223657900_lam13641-bib-0004 article-title: Microbiological profile of vaginal swabs publication-title: J Evol Med Dental Sci doi: 10.14260/jemds/80 contributor: fullname: Bhat – volume: 9 start-page: 276 year: 2012 ident: 2023011712223657900_lam13641-bib-0007 article-title: Dectin-1 isoforms contribute to distinct Th1/Th17 cell activation in mucosal candidiasis publication-title: Cell Mol Immunol doi: 10.1038/cmi.2012.1 contributor: fullname: Carvalho – volume: 10 start-page: 7455 year: 2015 ident: 2023011712223657900_lam13641-bib-0013 article-title: Liquid crystal precursor mucoadhesive system as a strategy to improve the prophylactic action of Syngonanthus nitens (Bong.) Ruhland against infection by Candida krusei publication-title: Int J Nanomed doi: 10.2147/IJN.S92638 contributor: fullname: Dos Santos Ramos – volume: 22 start-page: 726 year: 1996 ident: 2023011712223657900_lam13641-bib-0037 article-title: Symptomatic vulvovaginitis due to fluconazole-resistant Candida albicans in a female who was not infected with human immunodeficiency virus publication-title: Clin Infect Dis doi: 10.1093/clinids/22.4.726 contributor: fullname: Sobel – volume: 72 start-page: 688 year: 2021 ident: 2023011712223657900_lam13641-bib-0039 article-title: The synergistic antifungal activity of resveratrol with azoles against Candida albicans publication-title: Lett Appl Microbiol doi: 10.1111/lam.13458 contributor: fullname: Wang – volume: 42 start-page: 673 year: 2001 ident: 2023011712223657900_lam13641-bib-0022 article-title: Ras links cellular morphogenesis to virulence byregulation of the MAP kinase and cAMP signalling pathways in the pathogenic fungus Candida albicans publication-title: Mol Microbiolol doi: 10.1046/j.1365-2958.2001.02672.x contributor: fullname: Leberer – volume: 10 start-page: 2364 year: 2019 ident: 2023011712223657900_lam13641-bib-0006 article-title: Targeting the aryl hydrocarbon receptor with indole-3-aldehyde protects from vulvovaginal candidiasis via the IL-22-IL-18 cross-talk publication-title: Front Immunol doi: 10.3389/fimmu.2019.02364 contributor: fullname: Borghi – volume: 532 start-page: 64 year: 2016 ident: 2023011712223657900_lam13641-bib-0027 article-title: Candidalysin is a fungal peptide toxin critical for mucosal infection publication-title: Nature doi: 10.1038/nature17625 contributor: fullname: Moyes |
SSID | ssj0008129 |
Score | 2.4079263 |
Snippet | Vulvovaginal candidiasis (VVC) is an infectious disease caused mainly by Candida albicans. Kangfuxin (KFX) is a traditional Chinese medicine preparation made... Abstract Vulvovaginal candidiasis (VVC) is an infectious disease caused mainly by Candida albicans. Kangfuxin (KFX) is a traditional Chinese medicine... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 564 |
SubjectTerms | Animals antifungal Antifungal activity Antifungal Agents - pharmacology Antifungal Agents - therapeutic use Body weight Candida albicans Candidiasis Candidiasis, Vulvovaginal - drug therapy Candidiasis, Vulvovaginal - microbiology Colonization Cytokines Female Fluconazole Fluconazole - pharmacology Fluconazole - therapeutic use Fungicides Health services Herbal medicine Hyphae Infectious diseases Interleukins Kangfuxin liquid Leukocytes (neutrophilic) Materia Medica - pharmacology Materia Medica - therapeutic use Mice Minimum inhibitory concentration murine model Mycelia Neutrophils Signs and symptoms Traditional Chinese medicine vaginal candidiasis Weight reduction Wound healing |
Title | The liquid Kangfuxin (KFX) has efficient antifungal activity and can be used in the treatment of vulvovaginal candidiasis in mice |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Flam.13641 https://www.ncbi.nlm.nih.gov/pubmed/34958703 https://www.proquest.com/docview/2639037936 https://search.proquest.com/docview/2615122743 |
Volume | 74 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS9xAFH-IIPTiR1t11ZZp6UEPkWySzTh4ktJFtHoQhT0IYT41dJtVs1nUm_9535ts4hcF8RYmL5Nk3sf8XvLmNwA_kgjziFBHgVCRCBKZmkCGvsQKxYUlckj6o3t0nO6fJQeD3mAGdpu1MDU_RPvBjTzDx2tycKnKJ06OA0Y1Wn7ROhHpESA6eaSOwolL1N9X0oCyoCmrEFXxtFc-n4teAczneNVPOP0FOG8eta4z-bNdjdW2vn_B4vjOd1mE-SkQZXu15SzBjC0-wly9NeXdJ3hA-2HD_LrKDTuUxYWrbvOCbR72B1vsUpbMeuoJnLGYpHIjDBnYGS2SoL0osM0w1BlTllWlNQwvRaDJ2qp2NnJsUg0no4n023KRsMnRVMu8JOG_GL4-w1n_1-nP_WC6XUOgY_TkAJXrEh72Ii55tytUqg3mRzp0hhulYy16iQwjI1KOLcoRqwzCTeeEUpxoz-JlmC1GhV0F5pyJDdecO8w-DXbcxb5FlO5Y7ZLEug58bxSXXdWsHFmTzeBYZn4sO7DRqDSbOmaZRYjIwhiDUtqBb-1pdCn6TyILO6pIhmAQputxB1ZqU2jvEmNCiSEOz2x6hf7_9tnvvSN_sPZ20XX4ENHyCl8ZtAGz45vKfkHQM1ZfvXX_Azme_Rg |
link.rule.ids | 315,786,790,1382,27955,27956,46327,46751 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRYheCpQ-FgoY1EN7SJVNsjGWuFTAatvd7aFqpb2gyE-I2mZbslkBN_45M84m0CKkqrfIGduJ5-EZe_wZYCeJMI4IdRQIFYkgkakJZOhTrJBcWAKHpB3d8XE6OEuOJr3JErxvzsLU-BDtghtphrfXpOC0IP2XluOIUZIWnVp_gOreI7X8ePIHPAqnLlGvsKQBxUELXCHK42mr3pyN_nExb3qsfsrpP4bPzcfWmSbn-9VM7euft3Ac7_s3T2B14Yuyg1p4nsKSLdbgYX075Y9n8AtFiF3k11Vu2FAWX1z1PS_Y7rA_2WNfZcmsR5_ASYtJyjhCq4GN0TkJuo4CywxDtjFlWVVaw7Aq-pqsTWxnU8fm1cV8Opf-Zi4iNjlKa5mXRHyJFmwdzvqfTj8MgsWNDYGOUZkD5K9LeNiLuOTdrlCpNhgi6dAZbpSOteglMoyMSDmWKEfAMuhxOieU4oR8Fm_AcjEt7BYw50xsuObcYQBqsOEuti2i9J3VLkms68DbhnPZVQ3MkTUBDY5l5seyA9sNT7OFbpZZhE5ZGKNdSjvwpn2NWkVbJbKw04poyBPCiD3uwGYtC20vMcaUaOXwza7n6P-7z0YHY__w_O6kr-HR4HQ8ykaHx8MXsBLRaQufKLQNy7NvlX2JPtBMvfKi_hsO0QFH |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VrUBc2vJqtw8wiEM5pMo62bhWT1XLqrBthRCV9oAU-QkRJVvIZlW49Z93xtkECkJC3CJnbCeeh2fs8WeAFynHOCI2PJKayyhVmY1UHFKskFw6AoekHd3Ts-z4PH0zHowXYL89C9PgQ3QLbqQZwV6Tgl9a_4uS44BRjhYdWl9Ks4RT5HX07id2FM5csllgySIKg-awQpTG01W9PRn94WHedljDjDNcgQ_ttzaJJp9366neNT9-g3H8z59ZheW5J8oOGtG5DwuufAB3mrspvz-EaxQgdlF8rQvLRqr86OuromQ7o-H4JfukKuYC9gROWUxRvhHaDGyMTknQZRRYZhkyjWnH6spZhlXR02RdWjubeDarL2aTmQr3chGxLVBWq6Ii4i9ovx7B-fDV-8PjaH5fQ2QSVOUIuetTEQ-4UKLflzozFgMkE3srrDaJkYNUxdzKTGCJ9gQrg_6m91JrQbhnyWNYLCelWwfmvU2sMEJ4DD8tNtzHtiXP9pzxaep8D563jMsvG1iOvA1ncCzzMJY92GpZms81s8o5umRxglYp68Gz7jXqFG2UqNJNaqIhPwjj9aQHa40odL0kGFGijcM3O4Ghf-8-Pzk4DQ8b_076FO6-PRrmJ6_PRptwj9NRi5AltAWL02-120YHaKqfBEG_AREF_-c |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+liquid+Kangfuxin+%28KFX%29+has+efficient+antifungal+activity+and+can+be+used+in+the+treatment+of+vulvovaginal+candidiasis+in+mice&rft.jtitle=Letters+in+applied+microbiology&rft.au=Ma%2C+J&rft.au=Yang%2C+Y-C&rft.au=Su%2C+L-Q&rft.au=Qin%2C+D-M&rft.date=2022-04-01&rft.eissn=1472-765X&rft.volume=74&rft.issue=4&rft.spage=564&rft_id=info:doi/10.1111%2Flam.13641&rft_id=info%3Apmid%2F34958703&rft.externalDocID=34958703 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0266-8254&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0266-8254&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0266-8254&client=summon |